Brain tissue removed during surgery revealed a promising Alzheimer's inflammation target, the article reports.

Researchers pinpointed the P2X7 receptor as a catalyst for neuroinflammation.

Blocking that receptor reduced inflammatory responses in human biological samples.

Findings may also apply to traumatic brain injury and Parkinson's disease.

Scientists are evaluating existing medicines that already interact with the pathway.

Human tissue data could speed translation better than animal models alone.

Repurposing known drugs might skip some costly early development steps.

Teams hope the work leads to clinical trials aimed at slowing cognitive decline.

Read the full article for more details on the P2X7 Alzheimer's target.